Is Axon Enterprise (AXON) a risky stock?
As of July 21, 2026, Clavix grades Axon Enterprise (AXON) C+ for risk, a composite score of 61 out of 100 on an A+ to F scale, which puts AXON in the "average" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 21, 2026. Clavix regrades every trading day.
The five risk dimensions behind AXON's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how AXON scores on each, as of July 21, 2026.
What's moving AXON's risk right now
Company-specific signals Clavix flags behind AXON's current grade, drawn from recent news and filings as of July 21, 2026.
Analysts expect Axon's earnings to fall by double digits this quarter, which could weigh on the stock and shake investor confidence in the company's growth story.
Axon's Connected Devices unit is picking up speed, signaling stronger future revenue and reinforcing the bullish case for the stock.
What a C+ grade means
On the Clavix A+ to F scale, AXON's composite of 61 falls in the C band (50–64), read as "average." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell AXON or any security. Grades are risk indicators, not predictions of return. Data may be delayed.